Clinical trial

Effect of Neurostimulator Usage on Block Success in Costoclavicular Block: a Randomized Controlled Trial

Name
Neurostimulator Usage
Description
The need of a neurostimulator for a successful nerve block was questioned in different block types after ultrasound has become standard. The aim of this clinical study was to determine the effect of neurostimulator use on block success in costoclavicular block
Trial arms
Trial start
2020-02-01
Estimated PCD
2020-02-01
Trial end
2021-01-02
Status
Completed
Treatment
fentanyl will be added
If adequate anagesia is not provided with the block, 1 microgram/kg of fentanyl will be added
Arms:
Group USP, Group USPN
general anesthesia
If adequate anagesia is not provided with the block, general anesthesia will be administered.
Arms:
Group USP, Group USPN
Size
60
Primary endpoint
The block success rate (ratio of successful blocks to all blocks)
during procedure
Eligibility criteria
Inclusion Criteria: * Class I, II and III of American Society of Anesthesiologists (ASA) classification * being between 18 and 80 years of age, * body mass index (BMI) between 18 and 35 kg/m2 Exclusion Criteria: * Patients who did not give consent, * were above ASA III, * pregnant, * had a neuromuscular disease, * bleeding diathesis, * a local anesthetic allergy, * an infection in the area where nerve block would be applied, and * had previously operated from the infraclavicular fossa were not included in the study
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 60, 'type': 'ACTUAL'}}
Updated at
2023-01-31

1 organization

1 product

1 indication

Product
Fentanyl